Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.26.3
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Private Placement [Member]
Common Stock [Member]
A T M Offering [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
A T M Offering [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Private Placement [Member]
AOCI Attributable to Parent [Member]
A T M Offering [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Private Placement [Member]
Retained Earnings [Member]
A T M Offering [Member]
Retained Earnings [Member]
Private Placement [Member]
A T M Offering [Member]
Total
Balances (in shares) at Dec. 31, 2024     42,818,660                        
Balances at Dec. 31, 2024           $ 180,697     $ 23     $ (140,002)     $ 40,718
Issuance of common shares upon the exercise of stock options (in shares)     37,000                        
Issuance of common shares upon the exercise of stock options           94     0     0     94
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     3,805                        
Issuance of common shares upon the vesting and settlement of restricted stock units           0     0     0     0
Share-based compensation expense           867     0     0     867
Unrealized gain (loss) on marketable securities           0     (18)     0     (18)
Net loss           0     0     (7,707)     (7,707)
Balance (in shares) at Mar. 31, 2025     42,859,465                        
Balance at Mar. 31, 2025           181,658     5     (147,709)     33,954
Balances (in shares) at Dec. 31, 2024     42,818,660                        
Balances at Dec. 31, 2024           180,697     23     (140,002)     $ 40,718
Issuance of common shares upon the exercise of stock options (in shares)                             275,125
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)                             11,412
Unrealized gain (loss) on marketable securities                             $ 27
Net loss                             $ (24,026)
Issuance of common shares in settlement of deferred stock units (in shares)                             142,345
Issuance of common shares, net of offering costs (in shares)                           223,472  
Balance (in shares) at Sep. 30, 2025     52,077,439                        
Balance at Sep. 30, 2025           215,600     50     (164,028)     $ 51,622
Balances (in shares) at Dec. 31, 2024     42,818,660                        
Balances at Dec. 31, 2024           180,697     23     (140,002)     40,718
Issuance of common shares, net of offering costs (in shares)                           1,724,472  
Balance (in shares) at Dec. 31, 2025     53,742,370                        
Balance at Dec. 31, 2025           228,829     50     (172,768)     56,111
Balances (in shares) at Mar. 31, 2025     42,859,465                        
Balances at Mar. 31, 2025           181,658     5     (147,709)     33,954
Issuance of common shares upon the exercise of stock options (in shares)     66,875                        
Issuance of common shares upon the exercise of stock options           163     0     0     163
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     3,803                        
Issuance of common shares upon the vesting and settlement of restricted stock units           0     0     0     0
Share-based compensation expense           771     0     0     771
Unrealized gain (loss) on marketable securities           0     (19)     0     (19)
Net loss           0     0     (7,699)     (7,699)
Issuance of common shares in settlement of deferred stock units (in shares)     142,345                        
Balance (in shares) at Jun. 30, 2025     43,072,488                        
Balance at Jun. 30, 2025           182,592     (14)     (155,408)     27,170
Issuance of common shares upon the exercise of stock options (in shares)     171,250                        
Issuance of common shares upon the exercise of stock options           465     0     0     465
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     3,804                        
Issuance of common shares upon the vesting and settlement of restricted stock units           0     0     0     0
Share-based compensation expense           1,016     0     0     1,016
Unrealized gain (loss) on marketable securities           0     64     0     64
Net loss           0     0     (8,620)     (8,620)
Issuance of common shares, net of offering costs (in shares) 8,606,425 223,472                          
Issuance of common shares, net of offering costs       $ 29,977 $ 1,550   $ 0 $ 0   $ 0 $ 0   $ 29,977 $ 1,550  
Balance (in shares) at Sep. 30, 2025     52,077,439                        
Balance at Sep. 30, 2025           215,600     50     (164,028)     51,622
Balances (in shares) at Dec. 31, 2025     53,742,370                        
Balances at Dec. 31, 2025           228,829     50     (172,768)     56,111
Issuance of common shares upon the exercise of stock options (in shares)     140,136                        
Issuance of common shares upon the exercise of stock options           420     0     0     420
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     839                        
Issuance of common shares upon the vesting and settlement of restricted stock units           0     0     0     0
Share-based compensation expense           822     0     0     822
Unrealized gain (loss) on marketable securities           0     (76)     0     (76)
Net loss           0     0     (10,042)     (10,042)
Balance (in shares) at Mar. 31, 2026     53,883,345                        
Balance at Mar. 31, 2026           230,071     (26)     (182,810)     47,235
Balances (in shares) at Dec. 31, 2025     53,742,370                        
Balances at Dec. 31, 2025           228,829     50     (172,768)     $ 56,111
Issuance of common shares upon the exercise of stock options (in shares)                             212,587
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)                             2,517
Unrealized gain (loss) on marketable securities                             $ (105)
Net loss                             (31,491)
Balance (in shares) at Sep. 30, 2026     53,957,474                        
Balance at Sep. 30, 2026           232,973     (55)     (204,259)     28,659
Balances (in shares) at Mar. 31, 2026     53,883,345                        
Balances at Mar. 31, 2026           230,071     (26)     (182,810)     47,235
Issuance of common shares upon the exercise of stock options (in shares)     41,513                        
Issuance of common shares upon the exercise of stock options           135     0     0     135
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     839                        
Issuance of common shares upon the vesting and settlement of restricted stock units           0     0     0     0
Share-based compensation expense           1,118     0     0     1,118
Unrealized gain (loss) on marketable securities           0     (11)     0     (11)
Net loss           0     0     (10,139)     (10,139)
Balance (in shares) at Jun. 30, 2026     53,925,697                        
Balance at Jun. 30, 2026           231,324     (37)     (192,949)     38,338
Issuance of common shares upon the exercise of stock options (in shares)     30,938                        
Issuance of common shares upon the exercise of stock options           116     0     0     116
Issuance of common shares upon the vesting and settlement of restricted stock units (in shares)     839                        
Issuance of common shares upon the vesting and settlement of restricted stock units           0     0     0     0
Share-based compensation expense           1,533     0     0     1,533
Unrealized gain (loss) on marketable securities           0     (18)     0     (18)
Net loss           0     0     (11,310)     (11,310)
Balance (in shares) at Sep. 30, 2026     53,957,474                        
Balance at Sep. 30, 2026           $ 232,973     $ (55)     $ (204,259)     $ 28,659